Towatari M - Search Results

1

Constitutively active STAT5A and STAT5B in vitro and in vivo: mutation of STAT5 is not a frequent cause of leukemogenesis.

Yamada K, Ariyoshi K, Onishi M, Miyajima A, Hayakawa F, Towatari M, Saito H, Oka Y, Asano S, Nosaka T, Kitamura T. Yamada K, et al. Among authors: towatari m. Int J Hematol. 2000 Jan;71(1):46-54. Int J Hematol. 2000. PMID: 10729993

2

Differential constitutive activation between STAT-related proteins and MAP kinase in primary acute myelogenous leukaemia.

Hayakawa F, Towatari M, Iida H, Wakao H, Kiyoi H, Naoe T, Saito H. Hayakawa F, et al. Among authors: towatari m. Br J Haematol. 1998 Jun;101(3):521-8. doi: 10.1046/j.1365-2141.1998.00720.x. Br J Haematol. 1998. PMID: 9633897 Free article.

3

Tandem-duplicated Flt3 constitutively activates STAT5 and MAP kinase and introduces autonomous cell growth in IL-3-dependent cell lines.

Hayakawa F, Towatari M, Kiyoi H, Tanimoto M, Kitamura T, Saito H, Naoe T. Hayakawa F, et al. Among authors: towatari m. Oncogene. 2000 Feb 3;19(5):624-31. doi: 10.1038/sj.onc.1203354. Oncogene. 2000. PMID: 10698507

4

Protein expression and constitutive phosphorylation of hematopoietic transcription factors PU.1 and C/EBP beta in acute myeloid leukemia blasts.

Iida H, Towatari M, Iida M, Tanimoto M, Kodera Y, Ford AM, Saito H. Iida H, et al. Among authors: towatari m. Int J Hematol. 2000 Feb;71(2):153-8. Int J Hematol. 2000. PMID: 10745625

5

Functional regulation of GATA-2 by acetylation.

Hayakawa F, Towatari M, Ozawa Y, Tomita A, Privalsky ML, Saito H. Hayakawa F, et al. Among authors: towatari m. J Leukoc Biol. 2004 Mar;75(3):529-40. doi: 10.1189/jlb.0603389. J Leukoc Biol. 2004. PMID: 15001660

6

TEL-Syk fusion constitutively activates PI3-K/Akt, MAPK and JAK2-independent STAT5 signal pathways.

Kanie T, Abe A, Matsuda T, Kuno Y, Towatari M, Yamamoto T, Saito H, Emi N, Naoe T. Kanie T, et al. Among authors: towatari m. Leukemia. 2004 Mar;18(3):548-55. doi: 10.1038/sj.leu.2403266. Leukemia. 2004. PMID: 14749700

7

c-Myb acetylation at the carboxyl-terminal conserved domain by transcriptional co-activator p300.

Tomita A, Towatari M, Tsuzuki S, Hayakawa F, Kosugi H, Tamai K, Miyazaki T, Kinoshita T, Saito H. Tomita A, et al. Among authors: towatari m. Oncogene. 2000 Jan 20;19(3):444-51. doi: 10.1038/sj.onc.1203329. Oncogene. 2000. PMID: 10656693

8

In vivo treatment of mutant FLT3-transformed murine leukemia with a tyrosine kinase inhibitor.

Zhao M, Kiyoi H, Yamamoto Y, Ito M, Towatari M, Omura S, Kitamura T, Ueda R, Saito H, Naoe T. Zhao M, et al. Among authors: towatari m. Leukemia. 2000 Mar;14(3):374-8. doi: 10.1038/sj.leu.2401680. Leukemia. 2000. PMID: 10720129

9

Histone deacetylase 3 associates with and represses the transcription factor GATA-2.

Ozawa Y, Towatari M, Tsuzuki S, Hayakawa F, Maeda T, Miyata Y, Tanimoto M, Saito H. Ozawa Y, et al. Among authors: towatari m. Blood. 2001 Oct 1;98(7):2116-23. doi: 10.1182/blood.v98.7.2116. Blood. 2001. PMID: 11567998 Free article.

10

Lack of constitutive activation of MAP kinase pathway in human acute myeloid leukemia cells with N-Ras mutation.

Iida M, Towatari M, Nakao A, Iida H, Kiyoi H, Nakano Y, Tanimoto M, Saito H, Naoe T. Iida M, et al. Among authors: towatari m. Leukemia. 1999 Apr;13(4):585-9. doi: 10.1038/sj.leu.2401369. Leukemia. 1999. PMID: 10214865

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

44 results

Search Page

Filters